Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Core 1 O-glycans, also known as the T-antigen, are a fundamental subtype of mucin-type O-linked glycans. They consist of a galactose (Gal) molecule linked via a β1-3 bond to N-acetylgalactosamine (GalNAc), which is attached to serine or threonine residues on proteins. Core 1 O-glycans are involved in cell adhesion, immune responses, mucin formation, and protein folding. Aberrant expression is associated with diseases like cancer.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Core 1 O-glycan (None).